120 likes | 209 Views
Working with Industry - HCS as Catalysts of Technology Adoption Dr Darren Clark, CEO Medilink East Midlands. UK Life Sciences. Reproduced from HM Government’s Strength & Opportunity Report 2011. Regional Strengths. Med Tech Companies. 40 % of all companies.
E N D
Working with Industry - HCS as Catalysts of Technology AdoptionDr Darren Clark, CEOMedilink East Midlands
UK Life Sciences Reproduced from HM Government’s Strength & Opportunity Report 2011
Regional Strengths Med Tech Companies 40% of all companies + Largest Biotech Cluster in East of England Reproduced from HM Government’s Strength & Opportunity Report 2011
1st Challenge:New Product Development Traditional Markets Translate into product Identify solution Identify customer need Market to customer Everybody’s Happy
NPDin Healthcare Trust Clinician But who is the customer for health products? Patient Commissioner
2nd Challenge:Complex Innovation Landscape NTAC NIHR Companies Companies Professional Institutions International Regional NIC NHS Trusts/doctors etc DH / NHS CLAHRC / BRUs/ AHSC / HTCs NICE Medilink UK EUCOMED ABHI / BIVDA Medilinks Health Technologies KTN TSB/BIS CCGs FCO Researchers IMRCs /Catapults EU Commission Research Councils Universities
Medilink Model • Sector Specific • Industry association • Membership based • Not-for-profit • Geographical focus • Facilitate collaborations:
Medilink UK BioBusiness NI Medilink East Midlands Medilink North West Medilink South West MediWales Medilink West Midlands Medilink Yorkshire & Humber SEHTA ›1,000 members
Working Together Wealth Health HCS Wealth Health
Contact for Further InformationDr Darren ClarkChief ExecutiveMedilink East MidlandsBioCity NottinghamPennyfoot StreetNottinghamNG1 1GFTel: 0115 912 4330Fax: 0115 912 4331e-mail:darren@medilinkem.comweb:www.medilinkem.com